| Autor: |
Kimberly Stegmaier, Jaume Mora, Gad Getz, Todd R. Golub, Mark D. Fleming, Carlos Rodriguez-Galindo, Miguel N. Rivera, Angela Schwarz-Cruz y Celis, Ivan Imaz-Rosshandler, Matthew DeFelice, Brendan Blumenstiel, Sara Seepo, Daniel Auclair, Lauren Ambrogio, Mara Rosenberg, Petar Stojanov, Michael S. Lawrence, Kristian Cibulskis, Andrey Sivachenko, Aaron McKenna, Mariona Suñol, Cinzia Lavarino, Carmen de Torres, Aaron R. Thorner, Swapnil S. Mehta, Sachet A. Shukla, Scott L. Carter, Adam Kiezun, Monica L. Calicchio, Kyle C. Kurek, Gabriela Alexe, Amaro Taylor-Weiner, Chip Stewart, Brian D. Crompton |
| Rok vydání: |
2023 |
| Popis: |
This file contains supplementary methods, supplementary references, supplementary figures S1-S6, supplementary tables S1, S3-S6, S8-S15, and S17, and legends for all supplementary figures and tables. Supplementary Figure S1. Summary of Ewing sarcoma tumor and cell line cohorts. Supplementary Figure S2. RNASeq validation of mutations identified by WES and WGS. Supplementary Figure S3. Power calculations for the detection of significantly mutated genes. Supplementary Figure S4. Copy number variants in Ewing sarcoma tumors. Supplementary Figure S5. ETS1 deletions associated with EWS/FLI rearrangements. Supplementary Figure S6. Copy number variants in diagnostic vs. treated Ewing sarcoma tumors. Supplementary Figure S7. SCNAs in paired Ewing sarcoma tumor samples. Supplementary Table S1. Tissue samples. Supplementary Table S3. Multiply mutated genes. Supplementary Table S4. Rearrangements and fusions detected by WGS and RNASeq. Supplementary Table S5. Mutational significance for tumor/normal pairs. Supplementary Table S6. Rate of coding mutations in Ewing sarcoma tumors. Supplementary Table S8. Mutational significance for all tumors. Supplementary Table S9. Gene set enrichment analyses of mutated genes. Supplementary Table S10. Significance of arm-level SCNAs. Supplementary Table S11. Multiply mutated genes of interest in all sample cohorts. Supplementary Table S12. Immunohistochemical staining of STAG2 in Ewing sarcoma tumors. Supplementary Table S13. Gene set enrichment analyses of STAG2 expressing vs. STAG2 loss. Supplementary Table S14. Gene and gene-fragment RPKM Values for EWS and ETS genes. Supplementary Table S15. ETS1 copy-number changes. Supplementary Table S17. Gene set enrichment analyses of tumors vs. cell lines. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
